Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Sep;36(9):1578-86.
doi: 10.1007/s11064-011-0494-2. Epub 2011 May 12.

Regulatory mechanisms of nervous systems with glycosphingolipids

Affiliations
Review

Regulatory mechanisms of nervous systems with glycosphingolipids

Koichi Furukawa et al. Neurochem Res. 2011 Sep.

Abstract

A number of studies have suggested functions of sialic acid-containing glycosphingolipids (gangliosides) in the nervous system. However, results of analyses of the mutant mice lacking gangliosides suggested that they play crucial roles in the maintenance of integrity and repair of the nervous tissues. Furthermore, results of double knockout mice lacking all gangliosides except GM3 (GM3-only mice) suggested that deficiency of gangliosides induced complement activation and inflammation, leading to neurodegeneration. Generation of triple knockout mice by mating GM3-only mice and C3-deficient mice verified the involvement of complement systems in the inflammation and neurodegeneration. For the mechanisms of the complement activation, functional disorders of complement-regulatory proteins such as CD55 and CD59, which belong to GPI-anchored proteins, should be main factors. These results suggested that normal composition of gangliosides is essential for the maintenance of lipid rafts. Therefore, it was suggested that regulation of the complement systems and suppression of the inflammation should be important for the treatment of neurodegeneration, having common aspects with other neurodegenerative diseases such as Alzheimer disease.

PubMed Disclaimer

References

    1. Exp Neurol. 2003 Dec;184(2):887-903 - PubMed
    1. Behav Brain Res. 2009 Mar 2;198(1):74-82 - PubMed
    1. Proc Natl Acad Sci U S A. 2007 Aug 21;104(34):13678-83 - PubMed
    1. J Neurochem. 2007 Nov;103 Suppl 1:135-42 - PubMed
    1. Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4227-32 - PubMed

MeSH terms

LinkOut - more resources